Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
470.2 USD | +3.26% |
|
+2.90% | +15.55% |
Jun. 03 | Vertex Pharmaceuticals Insider Sold Shares Worth $2,033,159, According to a Recent SEC Filing | MT |
May. 31 | BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.37% | 22.48B | |
-9.70% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B | |
+80.51% | 9.02B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- RBC Adjusts Price Target on Vertex Pharmaceuticals to $424 From $417, Keeps Sector Perform Rating